Biomarker for Sanfilippo Type A-B-C-D Disease (BioSanfilippo)
NCT02298686 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-02-13
Summary
Development of a new MS-based biomarker for the ear-ly and sensitive diagnosis of Sanfilippo Disease Type A-B-C-D from blood (plasma)
Conditions
- Mental Retardation
- Developmental Delay
Sponsors & Collaborators
-
CENTOGENE GmbH Rostock
lead INDUSTRY
Principal Investigators
-
Peter Bauer, Prof. · Centogene GmbH
Eligibility
- Min Age
- 2 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-20
- Primary Completion
- 2021-02-28
- Completion
- 2021-02-28
Countries
- Egypt
- Germany
- India
- Sri Lanka
Study Locations
More Related Trials
-
Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
NCT01509768 ·Status: COMPLETED
-
Biomarker for Cystinosis Disease: BioCystinosis (BioCystinosis)
NCT02837523 ·Status: WITHDRAWN
-
A Natural History Study of Sanfilippo Syndrome Type D
NCT05648851 ·Status: COMPLETED
-
Natural History Study of Participants With Sanfilippo Syndrome Type IIIC
NCT05825131 ·Status: RECRUITING
-
A Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)
NCT02493998 ·Status: COMPLETED
-
Natural History Study to Characterise the Course of Disease Progression in Participants With Mucopolysaccharidosis Type IIIB
NCT02293408 ·Status: TERMINATED
-
A Retrospective Chart Review of Deceased Patients With Mucopolysaccharidosis Type IIIB
NCT02293382 ·Status: COMPLETED
-
A Study to Assess the Safety, Tolerability, and Efficacy of Long-term SOBI003 Treatment in Pediatric MPS IIIA Patients
NCT03811028 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
STXBP1 and SYNGAP1 Related Disorders Natural History Study
NCT06555965 ·Status: RECRUITING
-
Phase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA)
NCT06567769 ·Status: RECRUITING ·Phase: PHASE1
-
Intracerebral Gene Therapy for Sanfilippo Type A Syndrome
NCT01474343 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Prospective Natural History Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)
NCT03227042 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C
NCT00344331 ·Status: RECRUITING
-
Diagnostic Creteria of Acid Sphingomyelinase Deficiency (ASMD)
NCT07274826 ·Status: ACTIVE_NOT_RECRUITING
-
Intracerebral Gene Therapy in Children With Sanfilippo Type B Syndrome
NCT03300453 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Open-label Study of Anakinra in MPS III
NCT04018755 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Natural History Studies of Mucopolysaccharidosis III
NCT02037880 ·Status: COMPLETED
-
Prospective Collection of Biospecimen in Pediatric Patients and Adult Guardians Diagnosed With Glycogen Storage Disease Type 1B (GSD1b)
NCT05915910 ·Status: TERMINATED
-
A Study to Assess the Safety and Tolerability of SOBI003 in Pediatric MPS IIIA Patients
NCT03423186 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A)
NCT06181136 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Gene Transfer Study of ABO-102 in Patients With Middle and Advanced Phases of MPS IIIA Disease
NCT04088734 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Study to Improve the Awareness of Mucopolysaccharidosis Type II in Brazil
NCT05155488 ·Status: COMPLETED
-
Long-term Follow-up of Sanfilippo Type A Patients Treated by Intracerebral SAF-301 Gene Therapy
NCT02053064 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
An Observational Study in Children and Adults With Stargardt Disease
NCT06591806 ·Status: RECRUITING
-
Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-318 in Subjects With MPS I
NCT02702115 ·Status: TERMINATED ·Phase: PHASE1/PHASE2